Patented Therapeutic Medical Laser Technology
Business Objectives (2011 - 2012)Launch of TLC-2000 Biofeedback Therapeutic Laser employing a recurring revenue model
Commence TLC-3000 and PDC small animal in vivo pre-clinical trial for cancer destruction
A Sound Investment in Medical Treatment TechnologyAn investment in Theralase is an investment in the cutting edge of advanced medical treatment technology. A solid reputation built on advanced research and development, an experienced management team and proven patented technology make Theralase an investment with unlimited potential.
This posting does not constitute an offer of any securities for sale.This posting contains forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein.